RPS6KB1 and neoplasm: Consistent with the almost complete growth inhibition of diverse xenografts by Super-EBS, indicating the requirement for S6K1 in tumor growth, lung cancer cells knocked out for S6K1 by CRISPR/Cas9 targeting failed to grow tumors in mice.